Ketamine safety and tolerability in clinical trials for treatment-resistant depression

LB Wan, CF Levitch, AM Perez… - The Journal of …, 2014 - legacy.psychiatrist.com
Objective: Ketamine has demonstrated rapid antidepressant effects in patients with
treatment-resistant depression (TRD); however, the safety and tolerability of ketamine in this …
被引用次数：243 相关文章
[PDF] findpainrelief.com

[PDF][PDF] Ketamine Safety and Tolerability in Clinical Trials for Treatment-Resistant Depression

LB Wan, CF Levitch, AM Perez, JW Brallier… - J Clin …, 2015 - findpainrelief.com
Objective: Ketamine has demonstrated rapid antidepressant effects in patients with
treatmentresistant depression (TRD); however, the safety and tolerability of ketamine in this …
[PDF] cambridgebiotherapies.com

[PDF][PDF] Ketamine Safety and Tolerability in Clinical Trials for Treatment-Resistant Depression

LB Wan, CF Levitch, AM Perez… - J Clin …, 2015 - cambridgebiotherapies.com
Objective: Ketamine has demonstrated rapid antidepressant effects in patients with
treatmentresistant depression (TRD); however, the safety and tolerability of ketamine in this …

Ketamine Safety and Tolerability in Clinical Trials for Treatment-Resistant Depression

LB Wan, CF Levitch, AM Perez, JW Brallier… - J Clin …, 2015 - legacy.psychiatrist.com
Objective: Ketamine has demonstrated rapid antidepressant effects in patients with
treatmentresistant depression (TRD); however, the safety and tolerability of ketamine in this …
[PDF] ketamineinstitute.com

[PDF][PDF] Ketamine Safety and Tolerability in Clinical Trials for Treatment-Resistant Depression

LB Wan, CF Levitch, AM Perez, JW Brallier… - J Clin …, 2015 - ketamineinstitute.com
Objective: Ketamine has demonstrated rapid antidepressant effects in patients with
treatmentresistant depression (TRD); however, the safety and tolerability of ketamine in this …

Ketamine safety and tolerability in clinical trials for treatment-resistant depression

LB Wan, CF Levitch, AM Perez… - The Journal of …, 2015 - pubmed.ncbi.nlm.nih.gov
Objective Ketamine has demonstrated rapid antidepressant effects in patients with treatment-
resistant depression (TRD); however, the safety and tolerability of ketamine in this …

Ketamine Safety and Tolerability in Clinical Trials for Treatment-Resistant Depression

LB Wan, CF Levitch, AM Perez, JW Brallier… - The Journal of …, 2014 - psychiatrist.com
Objective: Ketamine has demonstrated rapid antidepressant effects in patients with
treatment-resistant depression (TRD); however, the safety and tolerability of ketamine in this …

Ketamine safety and tolerability in clinical trials for treatment-resistant depression.

LB Wan, CF Levitch, AM Perez, JW Brallier… - The Journal of …, 2015 - europepmc.org
Objective Ketamine has demonstrated rapid antidepressant effects in patients with treatment-
resistant depression (TRD); however, the safety and tolerability of ketamine in this …
[PDF] sovereignmindpsychiatry.com

[PDF][PDF] Ketamine Safety and Tolerability in Clinical Trials for Treatment-Resistant Depression

LB Wan, CF Levitch, AM Perez… - J Clin …, 2015 - sovereignmindpsychiatry.com
Objective: Ketamine has demonstrated rapid antidepressant effects in patients with
treatmentresistant depression (TRD); however, the safety and tolerability of ketamine in this …

Ketamine Safety and Tolerability in Clinical Trials for Treatment-Resistant Depression

LB Wan, CF Levitch, AM Perez, JW Brallier… - J Clin …, 2015 - psychiatrist.com
Objective: Ketamine has demonstrated rapid antidepressant effects in patients with
treatmentresistant depression (TRD); however, the safety and tolerability of ketamine in this …